When 3D Models Enter the Lab: A New Chapter in Drug Discovery Begins
The transition from traditional two-dimensional (2D) cultures to three-dimensional (3D) systems represents one of the most transformative shifts in contemporary drug discovery. In recent years, 3D technologies have begun to close the long-standing gap between preclinical models and human biology—providing more physiologically relevant systems for compound evaluation, efficacy prediction, and the reduction of costly late-stage …